InvestorsHub Logo

XenaLives

12/20/20 11:47 AM

#289023 RE: Investor2014 #289022

My original statement -


Nope, the drug is now a SAS drug.

Anavex has nothing to do with getting access.

It's just a matter of physician request and a yes or no answer.

As trial evidence piles up, saying "yes" becomes easier.



Your quote does not contradict that without exceptional interpretation of the words written.